A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults

NCT05636306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke

Interventions

DRUG: NoNO-42
DRUG: Placebo

Sponsor

NoNO Inc.